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Abstract
Myeloid cells such as resident retinal microglia (MG) or infiltrating blood-derived mac-
rophages (Mϕ) accumulate in areas of retinal ischemia and neovascularization (RNV)
and modulate neovascular eye disease. Their temporospatial distribution and biologi-
cal function in this process, however, remain unclarified. Using state-of-the-art
methods, including cell-specific reporter mice and high-throughput RNA sequencing
(RNA Seq), this study determined the extent of MG proliferation and Mϕ infiltration
in areas with retinal ischemia and RNV in Cx3cr1CreERT2:Rosa26-tdTomato mice and
examined the transcriptional profile of MG in the mouse model of oxygen-induced
retinopathy (OIR). For RNA Seq, tdTomato-positive retinal MG were sorted by flow
cytometry followed by Gene ontology (GO) cluster analysis. Furthermore, intraperito-
neal injections of the cell proliferation marker 5-ethynyl-20-deoxyuridine (EdU) were
performed from postnatal day (p) 12 to p16. We found that MG is the predominant
myeloid cell population while Mϕ rarely appears in areas of RNV. Thirty percent of
retinal MG in areas of RNV were EdU-positive indicating a considerable local MG cell
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expansion. GO cluster analysis revealed an enrichment of clusters related to cell divi-
sion, tubulin binding, ATPase activity, protein kinase regulatory activity, and chemo-
kine receptor binding in MG in the OIR model compared to untreated controls. In
conclusion, activated retinal MG alter their transcriptional profile, exhibit considerable
proliferative ability and are by far the most frequent myeloid cell population in areas
of ischemia and RNV in the OIR model thus presenting a potential target for future
therapeutic approaches.
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1 | INTRODUCTION
Retinal neovascularization (RNV) is a common feature in patients
with retinopathy of prematurity, retinal vein occlusion, and prolifera-
tive diabetic retinopathy, which are among the leading causes of
blindness worldwide (Sapieha et al., 2010). RNV can cause retinal
and vitreous bleeding, edema formation, and tractional retinal
detachments which in turn can lead to irreversible blindness if left
untreated. The cellular and molecular mechanisms underlying RNV
formation are not fully understood and an optimal treatment has
not yet been established. The introduction of therapies targeting
the vascular endothelial growth factor (VEGF) has enabled signifi-
cant progress in the treatment of patients with RNV, especially in
retinopathy of prematurity (Figueira et al., 2018; Stahl et al., 2018).
However, about 56% of diabetic patients with proliferative diabetic
retinopathy demonstrate persistent RNV despite intensive anti-
VEGF therapy and panretinal photocoagulation (Figueira et al.,
2018), highlighting the disease's complexity and pointing towards
other unaddressed disease-associated cellular and molecular
mechanisms.
Recent advances in our understanding of the pathogenesis of
ischemia-induced RNV have identified myeloid cells as key modulators
of disease progression. Myeloid cells, such as resident microglia
(MG) and recruited monocyte-derived macrophages (Mϕ) from the
blood, accumulate in areas of ischemia and RNV and have been
suggested to be a driving force for disease progression (Green, 1991;
Zeng, Green, & Tso, 2008). The degree to which different subtypes of
myeloid cells contribute to RNV formation or regression, however, is
undetermined. This is to a large extent due to the fact that resident
MG and blood-derived Mϕ cannot be differentiated based on the
expression of cell surface markers (Sousa, Biber, & Michelucci, 2017).
In this study, we used MG cell-specific reporter mice to dissect
the temporospatial distribution of resident MG and infiltrating Mϕ
and to assess the proliferative capacity of MG in a mouse model of
ischemia-induced RNV. Furthermore, we exploited high-throughput
RNA Seq of isolated MG to investigate their expression profile in the
steady state as well as during retinal ischemia and RNV formation. In
contrast to the prevailing notion, we found that resident MG
proliferate and constitute the predominant myeloid cell population in
areas of ischemia and RNV, while the number of blood-derived Mϕ is
substantially lower.
2 | MATERIALS AND METHODS
2.1 | Mice
All animal experiments were approved by our local authority
(Regierungspräsidium Freiburg, Germany) and conformed to EU Direc-
tive 2010/63/EU. Cx3cr1CreERT2 and Rosa26-fl-stop-fl-tdTomato
(Rosa26-tdTomato) mice were bred on a C57BL/6J background under
specific pathogen-free conditions. Cx3cr1CreERT2 mice were crossed to
Rosa26-tdTomato mice to generate experimental Cx3cr1CreERT2:
Rosa26-tdTomato mice. C57BL/6J mice were used for protein and
cytokine analysis. All mice used in this study were negative for the
Rd8 (Crb1) mutation.
2.2 | Tamoxifen treatment
To induce nuclear CreER recombinase activity, young Cx3cr1CreERT2:
Rosa26-tdTomato mice were given a subcutaneous injection of 5 μl of
21 mg/ml tamoxifen (TAM, T5648-1G, Sigma-Aldrich, Taufkirchen,
Germany) dissolved in corn oil (C8267, Sigma-Aldrich) at postnatal
day p1. Corn oil- and phosphate-buffered saline (PBS)-injected mice
served as controls.
2.3 | Oxygen-induced retinopathy mouse model
Mouse pups and their nursing dam were kept in an oxygen supply
chamber at 75 ± 3% O2 from p7 to p12 and subsequently returned to
room air as previously described (C. Lange et al., 2009). All mice were
raised and kept at a constant temperature with a 12 hr light/dark
cycle. The bodyweight of each pup was closely monitored to ascertain
adequate metabolic health (Stahl et al., 2010). Pups were perfused
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with PBS as described below and culled by cervical translocation at
p7, p10, p12, or p17. Control mice (nOIR) were kept in room air and
sacrificed at respective time points.
2.4 | Fluorescence microscopy
After intracardiac perfusion with PBS followed by 4% paraformalde-
hyde (PFA), eyes were fixed in 4% PFA for 1 hr at 4C and processed
for flat-mounts as described previously (Wang et al., 2013). Primary
antibodies against IBA1 (AB178846, Abcam, Cambridge, United King-
dom; 019-19741, WAKO, Osaka, Japan; 234004, Synaptic Systems,
Göttingen, Germany), TMEM119 (400002, Synaptic Systems) or Colla-
gen IV (COL4, AB769, Merck Millipore, Billerica, MA) were added over
two nights at a dilution of 1:500 at 4C. Secondary antibodies were
added at a dilution of 1:500 (Alexa Fluor® 647 and Alexa Flour®
488, Life Technologies, Carlsbad, CA) overnight at 4C. Images of the
entire retina were taken using a Hamamatsu NanoZoomer S60
(Hamamatsu Photonics, Herrsching, Germany) to assess the retinal vas-
culature. To quantify MG cell numbers, confocal images were taken
using a Leica SP8 confocal microscope (Leica, Wetzlar, Germany).
2.5 | Identification of microglia and blood-derived
macrophages
Confocal images of the peripheral retina (P), the vaso-obliterative zone
(VO) and area of RNV were imaged as described above and compared
to retinal mid-periphery of control nOIR animals. IBA1+ cells were
quantified in the ganglion cell layer plus the inner plexiform layer (GCL
+ IPL) as well as in the outer plexiform layer (OPL) using Fiji ImageJ
(Schindelin et al., 2012). Resident MG cells were defined as IBA1+
tdTomato (Tom)+ cells and blood-derived infiltrating Mϕ as IBA1+Tom−.
The percentage of Tom+ cells was determined among all IBA1+ cells.
2.6 | In vivo EdU proliferation assay
EdU (50 μg per day at a concentration of 125 μg EdU per 100 μl PBS)
was applied intraperitoneally on five consecutive days from p12 to
p16 in oxygen-induced retinopathy (OIR)-treated Cx3cr1CreERT2:
Rosa26-tdTomato mice. Mice were sacrificed at p17. Intracardiac per-
fusion, eye fixation, and flat-mount preparation were performed as
described above. EdU was visualized by the Click-iT™ EdU Alexa
Fluor™ 647 Imaging Kit (C10340, Thermo Fisher Scientific, Waltham,
MA) according to the manufacturer's protocol followed by anti-
Collagen IV staining as described above.
2.7 | Flow cytometry
Eyecups of PBS-perfused mice were dissected to separate the retina
from adjacent tissue. Retinal tissue was dissociated by resuspension.
Peripheral blood samples were obtained by heart puncture. Dead cells
were excluded by incubation in fixable viability dye 506 (65-0866-14,
eBioscience, Thermo Fisher Scientific). Anti-CD16/CD32 Fc block
(553142, BD Pharmingen, BD Biosciences, Franklin Lakes, NJ) was
performed at 4C for 20 min at a concentration of 1:200 to avoid
unspecific binding. Cells were stained with antibodies directed against
CD45 (30-F11, 103133, BioLegend, San Diego, CA), CD11b (M1/70,
17-0112-83, eBioscience, Thermo Fisher Scientific), Ly6C (AL-21,
45-5932-82, eBioscience, Thermo Fisher) and Ly6G (1A8, 551460,
BD Pharmingen, BD Biosciences) at 4C for 20 min at a concentration
of 1:200. For blood analysis, 50 μl of blood were lysed using RBC
Lysis Buffer (00-4333-57, eBioscience, Thermo Fisher Scientific).
Anti-CD16/CD32 Fc block was performed at 4C for 20 min at a con-
centration of 1:200 to avoid unspecific binding. Cells were stained
with primary antibodies directed against CD45 (30-F11), CD11b
(M1/70), CD115 (1:100, 25-1152-82, eBioscience, Thermo Fisher Sci-
entific), Ly6C (AL-21) and Ly6G (1A8) at 4C for 20 min at a concen-
tration of 1:200 in the dark. Cells were washed and analyzed using a
FACSCanto II (BD Biosciences) for blood samples and MoFlo Astrios
EQ (Beckman Coulter, Brea, CA) to sort retinal cells. To obtain an
average of 10,000 retinal MG per sample for RNA Seq analysis the
retinas of 2 to 3 mice were FACS-sorted and pooled. The retina of
one mouse per OIR litter was used to confirm an efficient induction of
RNV and VO via immunofluorescence before performing RNA Seq
experiments. Data were acquired with FACSDiva software
(BD Pharmingen, BD Biosciences). Post-acquisition analysis was per-
formed using FlowJo software (Tree Star, Inc., Ashland, OR).
2.8 | Total RNA extraction
RNA extraction, library preparation, and RNA Seq were performed at
the Genomics Core Facility “KFB - Center of Excellence for Fluores-
cent Bioanalytics” (University of Regensburg, Germany; www.kfb-
regensburg.de). In brief, eyes were enucleated and total RNA was
extracted from isolated retinal MG and stabilized in RNA protect
buffer according to the RNeasy Plus Micro Kit protocol (74004,
QIAGEN, Hilden, Germany). Retinal MG were stored and shipped in
RNA protect buffer at 2–8C. After pelleting, the RNA protect buffer
was removed and replaced by RLT Plus and the samples were homog-
enized by vortexing for 30 s. Genomic DNA contamination was elimi-
nated using gDNA Eliminator spin columns. Next, ethanol was added,
and the samples were applied to RNeasy MinElute spin columns
followed by several wash steps. Finally, total RNA was eluted in 12 μl
of nuclease-free water. The RNA's purity and integrity were deter-
mined on the Agilent 2100 Bioanalyzer with the RNA 6000 Pico
LabChip reagent set (5067-1513, Agilent, Palo Alto, CA).
2.9 | RNA sequencing
In total 8 OIR and 8 nOIR microglia samples were analyzed using RNA
Seq. The SMARTer Ultra Low Input RNA Kit for Sequencing v4
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(Clontech Laboratories, Inc., Mountain View, CA) was used to generate
first-strand cDNA from 750 pg total RNA. Double-stranded cDNA was
amplified by LD PCR (12 cycles) and purified via magnetic bead clean-up.
Library preparation was carried out as described in the Illumina Nextera
XT Sample Preparation Guide (Illumina, Inc., San Diego, CA). Then,
150 pg of input cDNA were tagmented (tagged and fragmented) by the
Nextera XT transposome. The products were purified and amplified via a
limited-cycle PCR program to generate multiplexed sequencing libraries.
For the PCR step 1:5 dilutions of index 1 (i7) and index 2 (i5) primers
were used. The libraries were quantified using the KAPA SYBR FAST ABI
Prism Library Quantification Kit (Kapa Biosystems, Inc., Woburn, MA).
Equimolar amounts of each library were pooled and the pools then used
for cluster generation on the cBot with the TruSeq SR Cluster Kit v3
(GD-401-3001, Illumina, Cambridge, UK). The sequencing run was per-
formed on a HiSeq 1000 instrument using the indexed 50 cycles single-
read (SR) protocol and TruSeq SBS v3 Reagents according to the Illumina
HiSeq 1000 System User Guide. Image analysis and base calling resulted
in bcl files which were converted into fastq files with the bcl2fastq v2.18
software. These sequence data have been submitted to the Gene
Expression Omnibus database under accession number GSE132731.
Address is as follows: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE132731. The password is available from the corresponding
author upon request.
2.10 | Differential gene expression analysis and
data visualization
Sequencing data were uploaded to the public Galaxy web platform
(https://usegalaxy.org) to analyze the data (Afgan et al., 2016). Quality
control was performed with FastQC Galaxy Version 0.72 (Andrews,
2018). Reads were mapped to the mouse genome (Gencode M20)
with RNA STAR Galaxy Version 2.6.0b-1 (Dobin et al., 2013) and coun-
ted using featureCounts Galaxy Version 1.6.2 (Liao, Smyth, & Shi,
2014). Differential gene expression was analyzed using DESeq2 Galaxy
Version 2.11.40.2 (Love, Huber, & Anders, 2014). The output of
DESeq2 was imported to GNU R 3.5.1 and checked for plausibility of
results. Strict thresholds (log2 fold change [log2FC] ≥ 1 or ≤ −1,
p < .01) were applied to minimize false positives when interpreting
the differentially expressed genes (DEG) between OIR and nOIR con-
trol MG. Data visualization with volcano plots was performed using
the ggplot2 package. Heatmaps were created with the R package Com-
plexHeatmap 1.20.0 (Gu, Eils, & Schlesner, 2016). Gene enrichment
analysis was done using the R package clusterProfiler 3.10.1 (Yu,
Wang, Han, & He, 2012).
2.11 | Protein analysis
Proteins were isolated from retinal tissue of OIR and nOIR control
mice (n = 6 per group) using RIPA buffer (R0278, Sigma-Aldrich) con-
taining protease (Complete Tablets Mini, 0463159001, Roche, Basel,
Switzerland) and phosphatase inhibitors (Phosstop, 04906845001,
Roche). The amount of recovered protein was evaluated via colori-
metric assay (Pierce™ BCA Protein Assay Kit, 23225, Thermo Fisher
Scientific). To examine cytokine concentrations in retinal samples, we
used a multiarray electrochemiluminescence panel (R-Plex, Meso-
Scale Discovery, Rockville, MD) according to the manufacturer's
instructions. This kit simultaneously measured protein levels of Inter-
leukin (IL) 1 beta (IL1b), IL6, IL16, CC-chemokine ligand (CCL) 2, CCL3,
CCL4, tumor necrosis factor-alpha (TNFA), Transforming growth
factor-beta 1 (TGFB1) and Vascular Endothelial Growth Factor A
(VEGFA). These factors were chosen by relying on the RNA Seq
results of this study and represented relevant DEG in OIR MG com-
pared to steady-state MG. For statistical analysis, all values below the
detection limit were assigned to the respective values of the detection
limit.
2.12 | Statistical analysis
Statistical analysis was performed using GraphPad Prism (GraphPad
Software, Version 6.0, La Jolla, CA). Data were tested for normality
applying the D'Agostino-Pearson Omnibus test. If normality was
given, an unpaired t test was applied. If the data did not meet the
criteria of normality, the Mann–Whitney test was applied. Differences
were considered significant when p-value <.05.
3 | RESULTS
3.1 | Characterization of the Cx3cr1CreERT2:
Rosa26-tdTomato line in the retina of young mice
In the past, discrimination between resident retinal microglia (MG) and
peripheral blood-derived macrophages (Mϕ) in the diseased retina was
hampered by the lack of cell-specific markers and suitable mouse
models. We recently demonstrated that Cx3cr1CreERT2:Rosa26-YFPmice
allow to distinguish MG from infiltrating blood-derived Mϕ in the brain
of adult mice (Goldmann et al., 2013). To validate the potential of this
mouse model in young mice, we injected a single pulse of tamoxifen or
diluent (sham) at p1 in new-born Cx3cr1CreERT2:Rosa26-tdTomato mice
and assessed the recombination efficiency in retinal MG and in periph-
eral blood cells at p7, p10, p12, and p17 in the steady-state (Figure 1a).
The immunofluorescence analysis of young Cx3cr1CreERT2:
Rosa26-tdTomato mice revealed a regular pattern of ramified IBA1+
MG cells demonstrating a high recombination efficiency of tdTomato
at p7 (mean ± SD = 98.3 ± 1.9%), p10 (99.4 ± 0.4%), p12 (99.5 ± 0.1%),
and p17 (99.5 ± 0.5%). Sham-injected Cx3cr1CreERT2:Rosa26-tdTomato
mice in contrast, showed a low recombination efficiency at p7
(14.9 ± 5.4%), p12 (21.0 ± 5.5%), and p17 (24.3 ± 5.4%, Figure 1b,e),
indicating tamoxifen-independent recombination events in the Rosa26
locus which increase with age. In line with these results, flow-
cytometry analysis of CD45loCD11b+Ly6C−Ly6G− retinal MG at p17
confirmed high recombination efficiency of 99.0% (± 0.3%) in the
tamoxifen-treated group compared with 23.9% (± 2.0%) in the
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sham-treated group (Figure 1c,f). Since tamoxifen injection of
Cx3cr1CreERT2:Rosa26-tdTomato mice induces tdTomato expression in all
Cx3cr1-expressing cells including peripheral monocytes, we next assessed
the CreER recombination efficiency in peripheral blood monocytes at p7,
p10, p12, and p17. Flow cytometry analysis of CD45hiCD11b+
CD115+SSclo peripheral blood monocytes revealed a decreasing percent-
age of tdTomato+ peripheral monocytes over time following tamoxifen
treatment. While 42.0% (± 10.4%) of the monocytes expressed tdTomato
at p7, this number decreased to 2.5% (± 2.5%) at p10, 4.9% (± 2.5%) at
p12, and 0.8% (± 0.9%) at p17 indicating a rapid cell turnover of peripheral
monocytes that are constantly renewed by Cx3cr1-negative precursor
cells in the bone marrow (Figure 1d,g).
Taken together, these data demonstrate that early (p1) single-pulse
tamoxifen treatment of Cx3cr1CreERT2:Rosa26-tdTomato mice induces
efficient and persistent tdTomato expression in virtually all resident reti-
nal MG while the labeling of circulating monocytes rapidly subsides over
time due to steady turnover of these cells. This strategy allows discrimi-
nating retinal MG and infiltrating Mϕ in young mice in the OIR model.
3.2 | Temporospatial distribution of myeloid
subsets during retinal ischemia and neovascularization
in the OIR mouse model
To study the temporospatial distribution of resident retinal MG and
infiltrating Mϕ in the ischemic retina and in areas of RNV, we injected
tamoxifen in Cx3cr1CreERT2:Rosa26-tdTomato mice at p1 and assessed
the number of retinal MG and blood-derived infiltrating Mϕ at p10,
p12, and p17 in the OIR model (Figure 2a).
Immunofluorescence microscopy revealed that the morphology
and distribution pattern of myeloid cells changed considerably in the
OIR model. IBA1+ retinal myeloid cells displayed an amoeboid and
less-ramified morphology indicating an activated state (Figure 2b). At
p10 similar numbers of IBA1+ retinal myeloid cells were observed in
the periphery and vaso-obliterative area in the OIR group compared
with the nOIR group (Figure 2c). At p12, however, the absolute num-
ber of IBA1+ retinal myeloid cells was substantially increased in the
periphery and vaso-obliterative area in the OIR group compared to
the nOIR group (Figure 2c) indicating an onset of MG cell expansion
or migration between p10 and p12. Interestingly, only neglectable
numbers of IBA1+Tom− cells were detectable in the peripheral retina
and VO at p10 and p12 (Figure 2c, Figure S1) suggesting a low infil-
tration of blood-derived monocytes during this time. The distribution
of myeloid cells changed dramatically with the onset of RNV, which
in the OIR model typically develops from p14 onwards (Stahl et al.,
2010). The number of IBA1+ cells increased extensively in the VO of
the GCL + IPL at p17 compared to p12. Surprisingly, we identified
almost no IBA1+ cells in the OPL of the VO at p17 indicating a migra-
tion of IBA1+ cells from the outer towards the inner retina. The max-
imum of IBA1+ cell density at p17 was observed in the inner retina in
areas of RNV while it remained similar in the outer retina underneath
RNV compared to the periphery. Again, only a few IBA1+Tom− cells
(6.2 ± 4.0%) were apparent in the diseased retina at p17 and were
mainly restricted to areas of RNV in the GCL + IPL (Figure 2b,c). This
finding was confirmed by flow cytometry analysis of the retina at
p17, demonstrating that 96.1% (± 3.7%) of CD45loCD11b+
Ly6C−Ly6G− cells were Tom+ and only 3.9% (± 3.7%) Tom−
(Figure 2d). Flow cytometry analysis of peripheral blood confirmed
that only negligible numbers of CD45hiCD11b+CD115+SSclo circu-
lating monocytes expressed the tdTomato signal in the OIR model at
p10, p12, and p17 (p10: 4.7 ± 4.0%, p12: 4.1 ± 3.9%, p17:
0.5 ± 0.7%, Figure 2e). These findings are consistent with the blood
FACS results of the nOIR control group (see Figure 1g) and indicate
that the OIR model itself has no significant effect on the turnover
rate of peripheral blood monocytes.
Thus, our data indicate that IBA1+Tom+ resident MG consti-
tute the predominant myeloid cell population accumulating in
areas of retinal ischemia and neovascularization while
IBA1+Tom− blood-derived infiltrating Mϕ are only detectable in
small numbers.
F IGURE 1 Characterization of the Cx3cr1CreERT2:Rosa26-tdTomato line in the retina of young mice. (a) Experimental setup and timeline for
inducing recombination (injection of tamoxifen [TAM] or solvent [sham]) and for subsequent analysis in Cx3cr1CreERT2:Rosa26-tdTomato mice.
Breeding scheme of Cx3cr1CreERT2 mice containing the targeted Cx3cr1 locus with Rosa26-tdTomato indicator mice. Flow cytometry and
immunofluorescence analysis were performed at postnatal day (p) 7, p10, p12, and p17, respectively. (b) Direct fluorescence microscopic
visualization of retinal vessels (Collagen IV (COL4) staining, blue) and microglia (IBA1, green) at p17 following TAM (top) or sham (bottom)
injection. TAM injection at p1 leads to an efficient tdTomato (Tom, red) labeling of most microglia. In contrast, sham-treated animals exhibit a low
CreER recombination efficiency and tdTomato expression in IBA1+ cells. Arrows point to IBA1+ and Tom+ microglia which is magnified in the top
right corner of each image. OPL = outer plexiform layer. (c, d) Flow cytometry analysis of recombination efficacy in resident retinal microglia
(c) and monocytes (d) in Cx3cr1CreERT2:Rosa26-tdTomato mice. Retinal microglia were gated and isolated as a CD45loCD11b+Ly6C−Ly6G− cell
population from the retina. Monocytes were isolated and gated as a CD45hiCD11b+CD115+Ssclo cell population from peripheral blood. Both
retinal and blood myeloid cells were analyzed for their percentages of Tom+ cells. Parameters of cell population were defined by fluorescence
light units or scattered light units: FSC = forward scatter; SSC = sideward scatter. (e) Immunofluorescence quantification of tdTomato expression
in IBA1+ microglia of TAM- or sham-treated Cx3cr1CreERT2:Rosa26-tdTomato mice at p7, p10, p12, and p17. Sham group n = 17, TAM group
n = 20. (f, g) Flow cytometric quantification of the number of tdTomato-expressing microglia in the retina (f) and monocytes in the blood (g). Data
are expressed as mean ± SD. For the analysis of the retina two mice were analyzed after sham injection and 19 mice after TAM injection. For
blood analysis sham group n = 17, TAM group n = 24
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3.3 | Retinal microglia proliferate in areas of
ischemia and RNV
Since the low numbers of infiltrating peripheral Mϕ cannot account
for the two- to threefold increase in myeloid cells in the diseased ret-
ina, we next explored the proliferative capacity of retinal MG in the
ischemic and neovascular retina. For this purpose, we treated
tamoxifen-induced Cx3cr1CreERT2:Rosa26-tdTomato mice with daily
intraperitoneal injections of the proliferation marker EdU from p12 to
p16 following OIR incubation and assessed the number of proliferat-
ing EdU+Tom+ MG in the peripheral retina as well as in areas of retinal
ischemia and neovascularization at p17 (Figure 3a,b).
Besides many Tom−EdU+ cells that were most likely proliferating
endothelial cells, pericytes or astrocytes (Bucher, Stahl, Agostini, &
Martin, 2013), we detected several Tom+EdU+ MG in all three areas
of interest. Quantification of the absolute and relative numbers of
Tom+EdU+ MG revealed that overall 21.5% (± 1.6%) of retinal MG
(Tom+ cells) were EdU+ indicating a local microglia cell expansion from
p12 to p17 in the diseased retina. Interestingly, the majority of EdU+
MG were located within the inner retina (23.6 ± 1.9%) compared to
the outer retina (13.0 ± 2.7%, p < .01) and located in areas of RNV
(348.1 ± 91.5 cells/mm2, 29.9 ± 3.7%) compared to the VO
(105.4 ± 54.6 cells/mm2, 13.9 ± 5.5%) and peripheral retina
(145.6 ± 36.6 cells/mm2, 22.9 ± 4.8%, Figure 3c,d).
These observations demonstrate that the accumulation and
increase in retinal MG in areas of retinal ischemia and
neovascularization are at least partially attributable to local MG
proliferation.
3.4 | Transcriptional profiling of retinal microglia in
the OIR mouse model
Having established the quantitative changes in retinal myeloid cells,
we next explored qualitative functional changes in retinal MG in
the OIR model. For this purpose, we isolated Tom+ retinal MG
from tamoxifen-induced Cx3cr1CreERT2:Rosa26-tdTomato mice at
p17 following OIR incubation and performed high-throughput next-
generation RNA Seq for transcriptional analysis. Tom+ MG from the
retina of tamoxifen-induced Cx3cr1CreERT2:Rosa26-tdTomato mice
without OIR incubation served as controls (Figure 4a). The number
of retinal MG isolated per experimental sample was similar in
the OIR (9,461 ± 1,846 microglia cells) and nOIR groups
(8,925 ± 2,371 microglia cells, p = .82), thus allowing for direct
comparisons. All samples revealed high expression of MG cell
markers (including Cx3cr1, Hexb, Tmem119, Trem2) and very
low expression of neuronal (Thy1, Isl1, Gabra1, Map2), astrocytic
(Gfap, S100b, Tnc), and granulocytic (Mpo, S100a9) markers,
confirming the purity of our isolation procedure (Gautier et al.,
2012; Greenhalgh & David, 2014; Mildner et al., 2007; Yang,
Zhang, Yu, Yang, & Wang, 2014) (Figure S2). While Tmem119 and
Hexb expression were substantially reduced in OIR MG compared
to nOIR MG, as confirmed by TMEM119 immunohistochemistry,
Cx3cr1 and Trem2 expression in MG was stable in OIR compared
to nOIR condition (Figure S3). When applying strict thresholds,
a total of 304 DEG were detectable in MG in the OIR model com-
pared to controls. Of those genes, 261 genes were significantly
upregulated and 43 genes downregulated in OIR MG compared
to controls (Figure 4b,c). The five most prominent DEG increased
in MG in the OIR model according to the log2FC value included
the inhibitor of kappaB kinase epsilon (Ikbke, log2FC = 3.0, p = 1.2E−24),
heme oxygenase 1 (Hmox1, log2FC = 2.6, p = 2.2E−20), lectin, gal-
actose binding soluble 3 (Lgals3, log2FC = 2.4, p = 3.3E−16),
shogushin 2a (Sgo2a, log2FC = 2.4, p = 1.6E−15), and cyclin B1
(Ccnb1, log2FC = 2.3, p = 1.8E−18, Figure 4c). Of note, pro-
angiogenic factors such as Ang2, Epo, Nrp1, Pgf or Vegf-a, which are
important mediators in RNV development were not significantly
increased in OIR MG compared to control MG (Figure S2). To con-
firm our gene expression results on protein level, we quantified the
protein expression of nine selected and disease-relevant DEG in
F IGURE 2 Temporospatial distribution of myeloid subsets during retinal ischemia and neovascularization. (a) Experimental setup. Tamoxifen
(TAM) was applied to 1-day-old Cx3cr1CreERT2:Rosa26-tdTomato mice leading to excision of the stop sequence followed by robust tdTomato (Tom)
expression in microglia. Together with their dam, pups were kept in an oxygen supply chamber at 75 ± 3% O2 from postnatal day (p) 7 to p12 and
returned to room air at p12 (OIR). Flow cytometry and immunofluorescence analysis were performed at p7, p10, p12, and p17, respectively.
(b) Left above: Retinal flat-mount stained for Collagen IV (COL4) demonstrating areas of retinal neovascularization (RNV), ischemia (VO = vaso-
obliterative zone) and normal peripheral vasculature (P) at p17 following OIR. Left: Higher magnification image showing retinal microglia (defined
as IBA1+Tom+) and infiltrating blood-derived Mϕ (defined as IBA1+Tom−) surrounding a neovascular tuft stained for COL4. Right: Higher
magnification images focusing on the distribution of retinal microglia (defined as IBA1+Tom+) and infiltrating blood-derived Mϕ (defined as
IBA1+Tom−) in the ganglion cell plus inner plexiform layer (GCL + IPL, above) and outer plexiform layer (OPL, below) in areas of unaffected
vasculature (P), retinal neovascularization (RNV) and ischemia (VO). Pictures are representative of six mice analyzed in two independent
experiments. Arrows point to IBA1+Tom+ microglia and asterisks indicate IBA1+Tom− blood-derived macrophages which are magnified in the top
right corner of each image. (c) Absolute numbers (left) and the percentage (right) of myeloid subsets in the ischemic (VO), neovascular (RNV) and
peripheral (P) retina at p10 (top), p12 (middle), and p17 (bottom) were analyzed following OIR. Red columns represent IBA1+Tom+ microglia in
Cx3cr1CreERT2:Rosa26-tdTomato mice whereas green columns represent blood-derived IBA1+Tom− macrophages. Data represent mean ± SD.
N = 6 (p10), 10 (p12), and 6 (p17) mice per group. (d) Flow cytometric quantification of the number of tdTomato-expressing microglia in the retina
at p17 following OIR compared to untreated control mice (nOIR). Data represent means ± SD. N = 19 (nOIR) and 20 mice (OIR). (e) Flow
cytometric quantification of the number of tdTomato-expressing monocytes in the blood at p10, p12, and p17 following OIR. Data are expressed
as mean ± SD. N = 6 (p10), 9 (p12), and 9 mice (p17)
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F IGURE 3 Retinal microglia proliferate in areas of retinal ischemia and neovascularization. (a) Experimental setup. Tamoxifen (TAM) was
applied to 1-day-old Cx3cr1CreERT2:Rosa26-tdTomato mice leading to robust tdTomato (Tom) expression in microglia. Pups were kept at 75 ± 3%
O2 from postnatal day (p) 7 to p12 and returned to room air (OIR). Pups received a daily intraperitoneal injection of 5-ethynyl-20-deoxyuridine
(EdU) from p12 to p16 and were sacrificed at p17 for immunofluorescence analysis. (b) Retinal flat-mount stained for Collagen IV (COL4)
demonstrating areas of retinal neovascularization (RNV), ischemia (VO = vaso-obliterative zone) and normal peripheral vasculature (P) at p17
following OIR incubation. (c) Higher magnification images focusing on the distribution of retinal microglia (Tom+, red) that have undergone mitosis
(EdU+, green) in the ganglion cell plus inner plexiform layer (GCL + IPL) in areas of normal peripheral vasculature (P), RNV and VO. Arrows point to
retinal microglia (Tom+, red) which have undergone proliferation (Tom+EdU+, yellow), arrowheads point to retinal microglia which have not
undergone proliferation (Tom+EdU−, red) and asterisks illustrate nonmicroglial cells that have proliferated (Tom−EdU+, green). Higher
magnification images in the top right corner. Pictures are representative of five mice analyzed in one experiment. (d) Absolute numbers (top) and
percentages (bottom) of microglia with or without EdU signal in areas ofP, VO, and RNV at p17 following OIR. Columns represent
nonproliferating (red) and proliferating microglia (green) respectively. Data represent means ± SD. N = 5 per group
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the retina of OIR and control mice that were analyzable using a
commercially available multiplex protein analysis platform. The
chemokines CCL2 (OIR: 10.5 ± 6.3 pg/ml, nOIR: 1.6 ± 0 pg/ml,
p < .05), CCL3 (OIR: 12.6 ± 5.2 pg/ml, nOIR: 0.7 ± 0.2 pg/ml,
p < .005) and CXCL2 (OIR: 1.0 ± 1.0 pg/ml, nOIR: 0.1 ± 0 pg/ml,
p = .08) were increased in the OIR group retinas compared to
controls which recapitulates our RNA Seq analysis findings. In
contrast to their concentration in MG on RNA level, IL16
(OIR: 160.9 ± 40.4 pg/ml, nOIR: 88.9 ± 12 pg/ml) and VEGF
(OIR: 123.1 ± 19.3 pg/ml, nOIR: 21.4 ± 2.2 pg/ml, p < .05) which
served as a positive control (Clemens Lange et al., 2016) were
significantly increased in the OIR retina compared to controls
(Figure 4d). The corresponding protein concentrations of the DEG
Ccl4, Il1b, Il6, and Tnfa were below the detection rate and not
recorded (data not shown).
To further investigate the biological importance of the DEG,
we performed GO enrichment analysis. The GO enrichment
analysis revealed that numerous DEGs were involved in a variety of
biological processes, such as nuclear division (GO:0000280,
p = 4.4E−32), organelle fission (GO:0048285, p = 6.9E−30), regula-
tion of the mitotic cell cycle (GO:0000280, p = 1.5E−23), chromo-
some segregation (GO:0007059, p = 4.7E−30) and mitotic nuclear
division (GO:0140014, p = 4.4E−30) supporting the observation
of increased MG cell expansion in the OIR model (Figure 4e).
Molecular function GO enrichment analysis showed that the
upregulated genes were mainly involved in tubulin-binding
(GO:0015631, p = 4.1E−6), ATPase activity (GO:0016887,
p = 1.7E−5), microtubule-binding (GO:0008017, p = 1.1E−7), and
kinase and protein kinase regulatory activity (GO:0019207,
p = 1.6E−6; GO:0019887, p = 1.5E−6, Figure 4f). Furthermore,
GO clusters related to chemokine signaling such as chemokine
activity (GO: 0008009, p = .002), CCR chemokine receptor binding
(GO:0048020, p = .003) and cytokine receptor binding (GO:0005126,
p = .004) were significantly enriched in retinal microglia in the OIR model.
To visualize functionally enriched GO clusters, we used cnetplots
depicting the linkages of genes and biological concepts as a network
(Figure S4).
4 | DISCUSSION
4.1 | Cx3cr1CreERT2:Rosa26-tdTomato mice are a
suitable tool to investigate the role of retinal microglia
in the OIR mouse model
Our knowledge on retinal myeloid cell dynamics and turnover in
health and ischemic retinal disease is based on transplantation experi-
ments, where bone marrow from ubiquitously expressing green fluo-
rescent protein transgenic mice, for example, those driven by the
β-Actin promotor, was transplanted into irradiated wildtype recipients
(Kataoka et al., 2011). To exclude confounding variables such as trans-
plantation efficacy and irradiation-induced breakdown of the blood-
retinal barrier which clearly biased turnover experiments in the past
(Kezic & McMenamin, 2013), we used a distinct strategy in
Cx3cr1CreERT2:Rosa26-tdTomato mice to differentially investigate the
turnover and expansion of resident microglia cells and blood-derived
recruited myeloid cells in health and in a model for neovascular retinal
disease. We observed that a tamoxifen pulse treatment of newborn
Cx3cr1CreERT2:Rosa26-tdTomato mice led to almost complete and per-
sistent labeling of retinal MG, whereas the tdTomato labeling of circu-
lating Cx3cr1-expressing cells quickly subsided within 2 weeks. This
observation follows the findings of Goldmann et al. in adult
Cx3cr1CreERT2 mice crossed to a floxed Rosa26-dependent reporter
line (YFP) and can be explained by the rapid cell turnover of bone
marrow-derived blood monocytes in contrast to the low turnover rate
of MG (Goldmann et al., 2013; Wieghofer et al. 2015). Interestingly,
sham-injected newborn Cx3cr1CreERT2:Rosa26-tdTomato mice also rev-
ealed tdTomato expression in about 20% of retinal MG, which
increased over time, but not in circulating monocytes. These data indi-
cate an accumulation of spontaneous and tamoxifen-independent
CreER-mediated recombination events in the Rosa26 locus of
Cx3cr1CreERT2:Rosa26-tdTomato mice, and was reported previously in
brain MG (Weber et al., 2018). While that observation does not affect
the present study, it needs to be considered when working with
Cx3cr1CreERT2:Rosa26-tdTomato mice, especially when conducting
time- and CreER/loxP-dependent conditional knockout experiments.
F IGURE 4 Transcriptional alterations of retinal microglia in the context of retinal ischemia and neovascularization. (a) Experimental setup.
CD45loCD11b+Ly6C−Ly6G−Tom+ microglia of tamoxifen- and OIR-treated Cx3cr1CreERT2:Rosa26-tdTomato mice were isolated at postnatal day
(p) 17 using flow cytometry-based cell sorting and processed for RNA Seq and protein analysis. (b) Supervised heatmap clustering of the
304 differentially expressed genes (≤ 0.01 and log2FC ≥ 1) in microglia in control (nOIR) and OIR mice. N = 8 samples per group. (c) Volcano plot
displaying differentially expressed genes in retinal microglia in OIR and nOIR control tissues. The vertical axis (y-axis) corresponds to the mean
expression value of -log10 p-value, and the horizontal axis (x-axis) displays the log2 fold change value. The top 10 upregulated and top
5 downregulated expressed transcripts are labeled. Positive x-values represent upregulation and negative x-values represent downregulation.
(d) Comparison of RNA Seq results of isolated microglia and protein analysis of retinal tissue lysates under OIR and nOIR control condition
focusing on relevant and differentially expressed factors. mRNA levels are expressed as transcripts per million, protein levels as pg/μl. mRNA:
n = 8 samples per group, protein n = 5–6 animals per group. (e, f) Gene ontology (GO) enrichment analyses for the 304 differentially expressed
genes. Dot plot depicting the top 10 enriched GO terms with the largest gene ratios for biological processes (e) and molecular function (f) in order
of gene ratio. The size of the dots represents the number of genes in the significant differentially expressed gene list associated with the GO
term, and dots' colors represent the p-adjusted values
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4.2 | Origin of retinal myeloid cells in health and
during OIR
Having established that Cx3cr1CreERT2:Rosa26-tdTomato mice are suit-
able to selectively study microglia biology in young mice, we next
investigated the temporospatial distribution of resident MG and rec-
ruited blood-derived Mϕ in Cx3cr1CreERT2:Rosa26-tdTomato mice in
the steady state and in a mouse model for retinal ischemia and
neovascularization, the OIR model. Under homeostatic conditions,
almost all IBA1+ retinal myeloid cells were Tom+ MG and no blood-
derived infiltrating Mϕ (defined as IBA1+Tom−) were detected in the
retina. These findings concur with the prevailing notion of a stable ret-
inal microglia cell population that is not complemented by circulating
monocytes in the steady state (O'Koren, Mathew, & Saban, 2016).
Next, we assessed the number of IBA1+ myeloid cells in the retina
over the course of the OIR model and detected a substantial increase
of myeloid cells in the vascularized periphery and VO starting
between p10 and p12 as well as in areas of RNV at p17, a finding in
line with earlier reports (Davies, Eubanks, & Powers, 2006; Dejda
et al., 2014; Liyanage et al., 2016). The overall increase in myeloid
cells in the OIR model raises the question of the origin of these cells.
In contrast to the prevailing notion of a major influx of blood-derived
myeloid cells into the diseased retina (Dejda et al., 2014; Kataoka
et al., 2011), our data strongly suggest that resident MG constitute
the predominant myeloid cell population in areas of retinal ischemia
and neovascularization whereas blood-derived Mϕ play a negligible
role in terms of quantity. Kataoka and colleagues analyzed lethally
irradiated bone marrow-reconstituted mice and reported on a consid-
erable number of bone-marrow-derived cells accumulating in the ret-
ina, in particular in areas of RNV in the OIR model (Kataoka et al.,
2011). Although head shielding was used to suppress irradiation-
induced tissue damage and cytokine release attracting myeloid cells in
this study (Kierdorf, Katzmarski, Haas, & Prinz, 2013), the presence of
bone marrow in the bloodstream of young mice paired with (sub-)
lethal irradiation of the entire body early during development is likely
to exert secondary long-lasting systemic effects during postnatal
development and may have affected the results (Ajami, Bennett,
Krieger, Tetzlaff, & Rossi, 2007; Shemer et al., 2018). Dejda and col-
leagues demonstrated a proportional increase in Neuropilin1+ mono-
nuclear phagocytes in the OIR model, with a 155% rise at p17, and
postulated that this subpopulation was being recruited from the blood
during disease. The flow cytometric gating strategy used in their
study, which excluded Gr-1+ peripheral cells like monocytes, and neu-
trophils, however, makes it difficult to discriminate resident MG and
infiltrating blood-derived Mϕ with confidence (Dejda et al., 2014). In
addition, the usage of the Lyz2-Cre mouse model, which predomi-
nantly targets peripheral myeloid cells and to a lesser extent MG, is
likely to lead to mixed Neuropilin1+ and Neuropilin1− populations in
both, resident MG and peripheral myeloid cells (Goldmann et al.,
2013; Wieghofer et al. 2015). Of note, our RNA Seq data revealed
strong RNA expression of Neuropilin1 in retinal MG, indicating that
the increase in Neuropilin1+ mononuclear phagocytes observed by
Dejda et al. is compatible with a local proliferation of resident MG in
the OIR model. Furthermore, our study demonstrates that retinal MG
has a considerable capacity to proliferate in areas of retinal ischemia
and neovascularization. This finding concurs with previous studies in
the brain (Ladeby et al., 2005) but challenges earlier reports of low
proliferation of resident MG in the diseased OIR retina (Davies et al.,
2006; Dejda et al., 2014). However, in these studies, MG identifica-
tion was limited by the lack of a cell-specific marker or a suitable
in vivo model and was solely based on immunohistochemistry or
FACS analysis of Gr-1−F4/80+CD11b+ mononuclear phagocytes. Fur-
thermore, in contrast to our study, Bromodeoxyuridine was applied
only once after oxygen exposure, 24 hr before sacrifice, whereas our
study documents the cumulative MG proliferation capacity from p12
to p17. It is, therefore, possible that previous studies have under-
estimated the proliferative capacity of MG in the OIR model. How-
ever, as only every fifth retinal microglia cell had undergone division
in our study by postnatal day 17, proliferation alone seems insufficient
to account for the increased microglia cell number in the neovascular
zone. This is also suggested by the notion that only a small fraction of
MG undergoes more than one cell division cycle and that even fewer
cells proliferate repeatedly under diseased conditions (Tay, Mai,
Dautzenberg, Fernández-Klett, & Lin, 2017). Our finding that the
number of retinal MG decreases in the outer plexiform layer at p12
and is practically absent in the VO at p17 suggests a vertical migration
of retinal MG to the inner retina's site of injury. It is also possible that
a fraction of the accreting retinal MG originates from extraretinal cen-
tral nervous system areas and that they migrate from the optic nerve
or ciliary body and iris to the damaged retina as recently described
(Huang et al., 2018). Taken together, these observations strongly sug-
gest a local proliferation and migratory redistribution of MG in areas
of retinal ischemia and neovascularization which may be complemen-
ted by an influx of Tom+ myeloid cells from the optic nerve or ciliary
body (Huang et al., 2018).
4.3 | Transcriptional profiling of retinal microglia
during OIR
Previous studies have indicated that the depletion of mononuclear
phagocytes results in a reduction of pathological neovascularization in
the OIR model (Kataoka et al., 2011) and that MG induce angiogenesis
by expressing pro-angiogenic and inflammatory cytokines (Ding et al.,
2018). Unfortunately, comprehensive transcriptional analyses of retinal
MG during retinal ischemia and neovascularization have not been avail-
able. To address this issue and further unravel molecular functions and
biological processes in retinal MG in the context of retinal ischemia
and neovascularization, we isolated retinal MG at the peak of RNV
(p17) in the OIR model and performed high-throughput RNA Seq. Our
results demonstrate considerable differences in mRNA expression
between activated retinal MG in the OIR model compared to quiescent
microglia in the steady state. Activated retinal MG in the OIR model
showed downregulation of MG signature genes such as Tmem119 and
Hexb, which is consistent with previous studies showing reduced
expression of TMEM119 in activated retinal MG in mouse models of
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neovascular and degenerative diseases (O'Koren et al., 2019; Su et al.,
2019). GO cluster analysis revealed that processes related to cell divi-
sion were significantly upregulated in retinal MG during OIR,
supporting our immunohistochemical findings of local microglia cell
expansion. Among them, Igf1, Mif, Ccnb2, and Cdk1 which are known
to be essential for microglia cell proliferation in the central nervous
system (Arnò et al., 2014; O'Donnell, Frederick, Krady, Vannucci, &
Wood, 2002; Pepe et al., 2017). Furthermore, factors belonging to GO
clusters related to chemokine signaling, including Ccl2, Ccl3, Ccl4, Ccl7,
Nes, and Cxcl14 were upregulated in MG in the OIR model, emphasiz-
ing the involvement of these factors during microglia cell activation
and migration into the diseased retina. In contrast to the pro-
angiogenic role of retinal MG in neovascular eye disease postulated in
the literature, we did not observe upregulated pro-angiogenic factors
in MG such as Epo, Pgf, Ang2, or Vegf which are important mediators
for the development of RNV. In particular, the expression of Vegf in
retinal MG was negligible, confirming previous findings (Liyanage et al.,
2016) and indicating that retinal MG is neither a major source of VEGF
in the ischemic retina, nor do they contribute to development of RNV
by expressing VEGF. Of note, the results of this study are limited due
to the use of bulk RNA Seq, which averages the expression levels of
thousands of MG and may, therefore, fail to detect subtle but biologi-
cally meaningful differences between different MG subpopulations in
the diseased retina. This is particularly important in light of the identifi-
cation of distinct disease-associated MG in the brain, which represents
a subpopulation contributing to neurodegenerative brain disease
(Keren-Shaul et al., 2017). Future studies using single-cell RNA Seq are
therefore warranted to determine the precise role of different retinal
MG populations during the development of ischemia-induced RNV.
In summary, this study demonstrates that Cx3cr1CreERT2:
Rosa26-tdTomatomice are highly valuable to assess microglia cell biology
in young mice in the OIR mouse model. In contrast to the prevailing
notion, we found that resident MG do indeed proliferate, and that they
constitute the predominant myeloid cell population in areas of retinal
ischemia and neovascularization whereas blood-derived Mϕ play a minor
role in terms of quantity. On the transcriptional level, retinal MG revealed
a proliferating and migratory phenotype in the OIR model with an
upregulation of diverse pro-inflammatory cytokines which may contrib-
ute to ischemic neovascular eye disease. The intracellular pathways
unraveled in this study provide a basis for future studies aiming to modu-
late retinal MG in ischemic neovascular eye disease.
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